Point-of-care biomarkers in asthma management: Time to move forward
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu dopisy
PubMed
31505025
DOI
10.1111/all.14045
Knihovny.cz E-zdroje
- MeSH
- biologické markery MeSH
- bronchiální astma * diagnóza terapie MeSH
- lidé MeSH
- vyšetření u lůžka * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- Názvy látek
- biologické markery MeSH
Allergy Division Fundación Jimenez Díaz Madrid Spain
Department of Respiratory Medicine and Allergology Lund University Lund Sweden
Department of Women's and Children's Health Uppsala University Uppsala Sweden
Observational and Pragmatic Research Institute Singapore Singapore
Primary Care and Population Sciences University of Southampton Southampton UK
Respiratory Effectiveness Group Cambridgeshire UK
Service de Pneumologie Hôpital Cochin University Paris Descartes Paris France
Zobrazit více v PubMed
Diamant Z, Vijverberg S, Alving K, et al. Towards clinically applicable biomarkers for asthma - an EAACI position paper. Allergy. 2019; [Epub ahead of print].
Alving K, Malinovschi A. Basic aspects of exhaled nitric oxide. Eur Respir Monograph. 2010;49:1-31.
Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172(4):453-459.
Bjermer L, Alving K, Diamant Z, et al. Current evidence and future research needs for FeNO measurement in respiratory diseases. Respir Med. 2014;108(6):830-841.
Hambleton K, Connolly CM, Borg C, et al. Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects. Int J Chron Obstruct Pulmon Dis. 2017;12:2771-2775.
Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013;132(4):821-827.
Syk J, Malinovschi A, Johansson G, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1(6):639-648.
Honkoop PJ, Loijmans RJ, Termeer EH, et al. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care. J Allergy Clin Immunol. 2015;135(3):682-688.
Price DB, Buhl R, Chan A, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6(1):29-39.
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma